Abstract
More than 60% of all cancer patients in Europe and the USA are older than 65 years at the time of diagnosis. Despite this, elderly patients are generally under-represented in clinical trials. There is a lack of clinical trials to drive evidence-based decision making in the elderly cancer patients. In this review, we address the most important issue surrounding the treatment of older cancer patients: comorbidity assessment.
Original language | English |
---|---|
Pages (from-to) | 1605-1606 |
Number of pages | 2 |
Journal | European Review for Medical and Pharmacological Sciences |
Volume | 16 |
Issue number | 11 |
Publication status | Published - 2012 |
Keywords
- Elderly patients
- Geriatric oncology
- Radiochemotherapy
- Radiotherapy
ASJC Scopus subject areas
- Medicine(all)
- Pharmacology (medical)